75 0 2 0 2 B-upper_bound
+ 2 3 2 3 I-upper_bound
years 4 9 4 9 I-upper_bound
of 10 12 10 12 O
age 13 16 13 16 B-age
or 17 19 17 19 O
60 20 22 20 22 B-lower_bound
+ 22 23 22 23 I-lower_bound
years 24 29 24 29 I-lower_bound

Chemotherapy 0 12 30 42 B-treatment
, 12 13 42 43 O
radiotherapy 14 26 44 56 B-treatment
, 26 27 56 57 O
biologics 28 37 58 67 B-treatment
, 37 38 67 68 O
and/or 39 45 69 75 O
other 46 51 76 81 O
treatment 52 61 82 91 O
with 62 66 92 96 O
immunotherapy 67 80 97 110 B-treatment
not 81 84 111 114 O
completed 85 94 115 124 O
4 95 96 125 126 B-upper_bound
weeks 97 102 127 132 I-upper_bound
prior 103 108 133 138 I-upper_bound
to 109 111 139 141 O
first 112 117 142 147 O
dose 118 122 148 152 O
of 123 125 153 155 O
study 126 131 156 161 B-treatment
drug 132 136 162 166 I-treatment

Eastern 0 7 167 174 B-clinical_variable
Cooperative 8 19 175 186 I-clinical_variable
Oncology 20 28 187 195 I-clinical_variable
Group 29 34 196 201 I-clinical_variable
( 35 36 202 203 I-clinical_variable
ECOG 36 40 203 207 I-clinical_variable
) 40 41 207 208 I-clinical_variable
performance 42 53 209 220 I-clinical_variable
status 54 60 221 227 I-clinical_variable
less 61 65 228 232 O
than 66 70 233 237 O
or 71 73 238 240 O
equal 74 79 241 246 O
to 80 82 247 249 O
3 83 84 250 251 B-upper_bound

Histopathologically 0 19 252 271 O
- 19 20 271 272 O
confirmed 20 29 272 281 O
diagnosis 30 39 282 291 O
of 40 42 292 294 O
classical 43 52 295 304 B-cancer
Hodgkin 53 60 305 312 I-cancer
lymphoma 61 69 313 321 I-cancer
( 70 71 322 323 O
Parts 71 76 323 328 O
A 77 78 329 330 O
, 78 79 330 331 O
B 80 81 332 333 O
, 81 82 333 334 O
C 83 84 335 336 O
, 84 85 336 337 O
D 86 87 338 339 O
, 87 88 339 340 O
and 89 92 341 344 O
E 93 94 345 346 O
) 94 95 346 347 O

History 0 7 348 355 O
of 8 10 356 358 O
another 11 18 359 366 O
malignancy 19 29 367 377 B-cancer
within 30 36 378 384 O
1 37 38 385 386 B-upper_bound
year 39 43 387 391 I-upper_bound
before 44 50 392 398 O
first 51 56 399 404 O
dose 57 61 405 409 O
of 62 64 410 412 O
study 65 70 413 418 O
drug 71 75 419 423 O
( 76 77 424 425 O
Parts 77 82 425 430 O
E 83 84 431 432 O
and 85 88 433 436 O
F 89 90 437 438 O
only 91 95 439 443 O
) 95 96 443 444 O

Ineligible 0 10 445 455 O
for 11 14 456 459 O
initial 15 22 460 467 B-treatment
conventional 23 35 468 480 I-treatment
combination 36 47 481 492 I-treatment
chemotherapy 48 60 493 505 I-treatment
for 61 64 506 509 O
HL 65 67 510 512 B-cancer
( 68 69 513 514 O
Parts 69 74 514 519 O
A 75 76 520 521 O
, 76 77 521 522 O
B 78 79 523 524 O
, 79 80 524 525 O
C 81 82 526 527 O
, 82 83 527 528 O
D 84 85 529 530 O
, 85 86 530 531 O
E 87 88 532 533 O
) 88 89 533 534 O
or 90 92 535 537 O
CD30 93 97 538 542 B-cancer
- 97 98 542 543 I-cancer
expressing 98 108 543 553 I-cancer
PTCL 109 113 554 558 I-cancer
( 114 115 559 560 O
Part 115 119 560 564 O
F 120 121 565 566 O
) 121 122 566 567 O

Measurable 0 10 568 578 O
disease 11 18 579 586 O
of 19 21 587 589 O
at 22 24 590 592 O
least 25 30 593 598 O
1.5 31 34 599 602 B-lower_bound
cm 35 37 603 605 I-lower_bound
as 38 40 606 608 O
documented 41 51 609 619 O
by 52 54 620 622 O
radiographic 55 67 623 635 B-treatment
technique 68 77 636 645 I-treatment

Symptomatic 0 11 646 657 O
neurologic 12 22 658 668 B-chronic_disease
disease 23 30 669 676 I-chronic_disease
compromising 31 43 677 689 O
instrumental 44 56 690 702 O
activities 57 67 703 713 O
of 68 70 714 716 O
daily 71 76 717 722 O
living 77 83 723 729 O
or 84 86 730 732 O
requiring 87 96 733 742 O
medication 97 107 743 753 B-treatment

Treatment 0 9 754 763 B-treatment
- 9 10 763 764 I-treatment
na√Øve 10 15 764 769 I-treatment
patients 16 24 770 778 I-treatment
with 25 29 779 783 I-treatment
CD30 30 34 784 788 I-treatment
- 34 35 788 789 O
expressing 35 45 789 799 O
PTCL 46 50 800 804 O
( 51 52 805 806 O
Part 52 56 806 810 O
F 57 58 811 812 O
) 58 59 812 813 O

have 0 4 814 818 O
declined 5 13 819 827 O
initial 14 21 828 835 O
conventional 22 34 836 848 B-treatment
combination 35 46 849 860 I-treatment
chemotherapy 47 59 861 873 I-treatment
for 60 63 874 877 O
HL 64 66 878 880 B-cancer
( 67 68 881 882 O
Parts 68 73 882 887 O
A 74 75 888 889 O
, 75 76 889 890 O
B 77 78 891 892 O
, 78 79 892 893 O
C 80 81 894 895 O
, 81 82 895 896 O
and 83 86 897 900 O
D 87 88 901 902 O
) 88 89 902 903 O

have 0 4 904 908 O
depressed 5 14 909 918 O
ejection 15 23 919 927 B-clinical_variable
fraction 24 32 928 936 I-clinical_variable
or 33 35 937 939 O
moderately 36 46 940 950 O
severe 47 53 951 957 O
renal 54 59 958 963 B-chronic_disease
dysfunction 60 71 964 975 I-chronic_disease
( 72 73 976 977 O
Parts 73 78 977 982 O
E 79 80 983 984 O
and 81 84 985 988 O
F 85 86 989 990 O
only 87 91 991 995 O
) 91 92 995 996 O

